A Study of LY2835219 in Healthy Participants

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

Participants in this study will receive 3 single oral doses of LY2835219 at least 14 days apart. One dose will be given with a standard meal, one dose with a high-fat meal and one dose without food. The study will evaluate the effects of the standard and high-fat meals on how much drug gets into the bloodstream. Side effects will be documented. This study is approximately 43 days, not including screening. Screening is required within 28 days prior to the start of the study.

Key facts

Study ID

NCT02059148

Run by

Eli Lilly and Company

People needed

24

Starts

2014-02-01

Expected to finish

2014-08-01

Last updated by the study team

2019-01-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy sterile males or surgically sterile or postmenopausal females
• Have a body mass index (BMI) of 18 to 32 kilogram per meter square (kg/m\^2), inclusive, at screening
• Are able to eat a high-fat, high-calorie meal

You may not qualify if…

• Participated in a clinical trial involving investigational product within 30 days
• Abnormal blood pressure
• Have an abnormality in the 12-lead electrocardiogram (ECG) that, in the opinion of the investigator, increases the risks associated with participating in the study
• Have donated blood of more than 500 milliliter (mL) within the last month
• Show evidence of human immunodeficiency virus, hepatitis B or hepatitis C

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.